{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:03:40Z","timestamp":1786993420340,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Fujian Province","award":["2025J01142"],"award-info":[{"award-number":["2025J01142"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173180"],"award-info":[{"award-number":["82173180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Special Project of Central Government for Local Science and Technology Development of Fujian Province","award":["2023L3011"],"award-info":[{"award-number":["2023L3011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41141-x","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:10:22Z","timestamp":1773753022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kynurenine promotes angiogenesis through mTOR signaling in head and neck squamous cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Shuoqi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genggeng","family":"zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohua","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"3","key":"41141_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"41141_CR2","doi-asserted-by":"crossref","unstructured":"Head and neck squamous cell carcinoma [J]. Nat. Rev. Dis. Primers 2020, 6 (1): 93 .","DOI":"10.1038\/s41572-020-00233-2"},{"key":"41141_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semcancer.2019.09.011","volume":"61","author":"AWY Chai","year":"2020","unstructured":"Chai, A. W. Y., Lim, K. P. & Cheong, S. C. Translational genomics and recent advances in oral squamous cell carcinoma. Semin. Cancer Biol. 61, 71\u201383 (2020).","journal-title":"Semin. Cancer Biol."},{"issue":"11","key":"41141_CR4","first-page":"1219","volume":"28","author":"O Alabaku","year":"2022","unstructured":"Alabaku, O., Laffey, T. N., Suh, K. & Li, M. Trends in endpoint use in pivotal trials and efficacy for US Food and Drug Administration-approved solid tumor therapies, 1995\u20132021. J. Manag. Care Spec. Pharm. 28(11), 1219\u20131223 (2022).","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"9","key":"41141_CR5","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/annonc\/mdu216","volume":"25","author":"TY Seiwert","year":"2014","unstructured":"Seiwert, T. Y. et al. A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck. Ann. Oncol. 25(9), 1813\u20131820 (2014).","journal-title":"Ann. Oncol."},{"issue":"3","key":"41141_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","volume":"77","author":"C Raggi","year":"2022","unstructured":"Raggi, C., Taddei, M. L., Rae, C., Braconi, C. & Marra, F. Metabolic reprogramming in cholangiocarcinoma. J. Hepatol. 77(3), 849\u2013864 (2022).","journal-title":"J. Hepatol."},{"issue":"8","key":"41141_CR7","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","volume":"35","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. Emerging therapies in cancer metabolism. Cell Metab. 35(8), 1283\u20131303 (2023).","journal-title":"Cell Metab."},{"issue":"25","key":"41141_CR8","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","volume":"378","author":"CD Dinardo","year":"2018","unstructured":"Dinardo, C. D. et al. Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML. N. Engl. J. Med. 378(25), 2386\u20132398 (2018).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"41141_CR9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa, G. K. et al. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): A multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol. 21(6), 796\u2013807 (2020).","journal-title":"Lancet Oncol."},{"issue":"18","key":"41141_CR10","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","volume":"389","author":"JV Heymach","year":"2023","unstructured":"Heymach, J. V. et al. Perioperative durvalumab for resectable non-small-cell lung cancer. N. Engl. J. Med. 389(18), 1672\u20131684 (2023).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"41141_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103446","volume":"9","author":"T Alonso-Gordoa","year":"2024","unstructured":"Alonso-Gordoa, T. et al. A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer. ESMO Open 9(6), 103446 (2024).","journal-title":"ESMO Open"},{"issue":"8","key":"41141_CR12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","volume":"20","author":"GV Long","year":"2019","unstructured":"Long, G. V. et al. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study [J]. Lancet Oncol. 20 (8), 1083\u20131097 (2019).","journal-title":"Lancet Oncol."},{"issue":"1","key":"41141_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson, D. E. et al. Head and neck squamous cell carcinoma [J]. Nat. Rev. Dis. Primers. 6 (1), 92 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"41141_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","volume":"20","author":"C Yao","year":"2023","unstructured":"Yao, C. et al. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies [J]. Cancer Biol. Med. 20 (1), 25\u201343 (2023).","journal-title":"Cancer Biol. Med."},{"key":"41141_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23148053","author":"L Alessandrini","year":"2022","unstructured":"Alessandrini, L. et al. Tumor-stroma ratio and programmed cell death ligand 1 expression in preoperative biopsy and matched laryngeal carcinoma surgical specimen. Int. J. Mol. Sci. 23(14), 8053\u00a0(2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"41141_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell.\u00a0100(1), 57\u201370 (2000).","journal-title":"Cell"},{"issue":"3","key":"41141_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell.\u00a086(3), 353\u2013364 (1996).","journal-title":"Cell"},{"key":"41141_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133339","author":"L Franz","year":"2021","unstructured":"Franz, L. et al. Epithelial-to-mesenchymal transition and neoangiogenesis in laryngeal squamous cell carcinoma.\u00a0Cancers.\u00a013(13), 3339 (2021).","journal-title":"Cancers"},{"issue":"10","key":"41141_CR19","doi-asserted-by":"publisher","first-page":"16978","DOI":"10.1002\/jcb.28959","volume":"120","author":"W Yuan","year":"2019","unstructured":"Yuan, W. et al. Biological and anti-vascular activity evaluation of ethoxy-erianin phosphate as a vascular disrupting agent. J. Cell. Biochem. 120(10), 16978\u201316989 (2019).","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"41141_CR20","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3892\/ijo.2017.3975","volume":"50","author":"J Pan","year":"2017","unstructured":"Pan, J. et al. Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition. Int. J. Oncol. 50(6), 2136\u20132144 (2017).","journal-title":"Int. J. Oncol."},{"issue":"7","key":"41141_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13613","volume":"57","author":"X Qi","year":"2024","unstructured":"Qi, X. et al. A bioenergetically-active ploy (glycerol sebacate)-based multiblock hydrogel improved diabetic wound healing through revitalizing mitochondrial metabolism. Cell Prolif. 57(7), e13613 (2024).","journal-title":"Cell Prolif."},{"key":"41141_CR22","doi-asserted-by":"publisher","DOI":"10.34133\/research.0425","volume":"7","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Golgi protein 73 promotes angiogenesis in hepatocellular carcinoma. Research 7, 0425 (2024).","journal-title":"Research"},{"issue":"D1","key":"41141_CR23","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672-d677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"41141_CR24","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms [J]. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"41141_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"41141_CR26","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","volume":"55","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Metabolic reprogramming and epigenetic modifications in cancer: From the impacts and mechanisms to the treatment potential. Exp. Mol. Med. 55(7), 1357\u20131370 (2023).","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"41141_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.it.2021.11.007","volume":"43","author":"RJ King","year":"2022","unstructured":"King, R. J., Singh, P. K. & Mehla, K. The cholesterol pathway: Impact on immunity and cancer. Trends Immunol. 43(1), 78\u201392 (2022).","journal-title":"Trends Immunol."},{"issue":"1","key":"41141_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01442-3","volume":"8","author":"M You","year":"2023","unstructured":"You, M. et al. Signaling pathways in cancer metabolism: Mechanisms and therapeutic targets. Signal Transduct. Target. Ther. 8(1), 196 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"41141_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05054-5","volume":"22","author":"X Ying","year":"2024","unstructured":"Ying, X., Zheng, X., Zhang, X., Yin, Y. & Wang, X. Kynurenine in IDO1(high) cancer cell-derived extracellular vesicles promotes angiogenesis by inducing endothelial mitophagy in ovarian cancer. J. Transl. Med. 22(1), 267 (2024).","journal-title":"J. Transl. Med."},{"key":"41141_CR30","doi-asserted-by":"publisher","DOI":"10.34133\/research.0368","volume":"7","author":"J Zhong","year":"2024","unstructured":"Zhong, J. et al. Uncovering the pre-deterioration state during disease progression based on sample-specific causality network entropy (SCNE). Research 7, 0368 (2024).","journal-title":"Research"},{"key":"41141_CR31","volume":"7","author":"P Pan","year":"2024","unstructured":"Pan, P. et al. High-resolution imaging and morphological phenotyping of C. elegans through stable robotic sample rotation and artificial intelligence-based 3-dimensional reconstruction. Research (Wash. D. C.) 7, 0513 (2024).","journal-title":"Research (Wash. D. C.)"},{"issue":"1","key":"41141_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","volume":"29","author":"SA Patel","year":"2023","unstructured":"Patel, S. A. et al. Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy. Clin. Cancer Res. 29(1), 30\u201339 (2023).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"41141_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu, Z. L., Chen, H. H., Zheng, L. L., Sun, L. P. & Shi, L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct. Target. Ther. 8(1), 198 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"41141_CR34","first-page":"476","volume":"22","author":"Y Cao","year":"2023","unstructured":"Cao, Y., Langer, R. & Ferrara, N. Targeting angiogenesis in oncology, ophthalmology and beyond. Nature Reviews: Drug Discovery 22(6), 476\u2013495 (2023).","journal-title":"Nature Reviews: Drug Discovery"},{"issue":"2","key":"41141_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF00437471","volume":"15","author":"PC Brooks","year":"1996","unstructured":"Brooks, P. C. Cell adhesion molecules in angiogenesis. Cancer Metastasis Rev. 15(2), 187\u2013194 (1996).","journal-title":"Cancer Metastasis Rev."},{"issue":"5","key":"41141_CR36","doi-asserted-by":"publisher","DOI":"10.31083\/FBL37456","volume":"30","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Xue, W., Pustovalova, M., Kuzmin, D. V. & Leonov, S. Chick embryo chorioallantoic membrane (CAM) model for cancer studies and drug evaluation. Front. Biosci. (Landmark Ed) 30(5), 37456 (2025).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"41141_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020929","author":"O Baru","year":"2021","unstructured":"Baru, O. et al. Angiogenesis in regenerative dentistry: Are we far enough for therapy?\u00a0Int. J. Mol. Sci. 22(2), 929\u00a0(2021).","journal-title":"Int. J. Mol. Sci."},{"key":"41141_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s41199-020-00051-9","volume":"5","author":"I Micaily","year":"2020","unstructured":"Micaily, I., Johnson, J. & Argiris, A. An update on angiogenesis targeting in head and neck squamous cell carcinoma. Cancers of the Head & Neck 5, 5 (2020).","journal-title":"Cancers of the Head & Neck"},{"key":"41141_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/jcm13154493","volume":"13","author":"P Prasad","year":"2024","unstructured":"Prasad, P., Jaber, M., Alahmadi, T. A., Almoallim, H. S. & Ramu, A. K. Solanine Inhibits Proliferation and Angiogenesis and Induces Apoptosis through Modulation of EGFR Signaling in KB-ChR-8-5 Multidrug-Resistant Oral Cancer Cells [J]. J. Clin. Med. 13, 15 (2024).","journal-title":"J. Clin. Med."},{"key":"41141_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jare.2024.01.016","volume":"67","author":"G Li","year":"2025","unstructured":"Li, G., Gao, J., Ding, P. & Gao, Y. The role of endothelial cell-pericyte interactions in vascularization and diseases. J. Adv. Res. 67, 269\u2013288 (2025).","journal-title":"J. Adv. Res."},{"key":"41141_CR41","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ijbiomac.2022.01.113","volume":"202","author":"X Zou","year":"2022","unstructured":"Zou, X. et al. Targeting the PDGF\/PDGFR signaling pathway for cancer therapy: A review. Int. J. Biol. Macromol. 202, 539\u2013557 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"41141_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155690","volume":"129","author":"D Zhang","year":"2024","unstructured":"Zhang, D. et al. Polyphyllin I ameliorates gefitinib resistance and inhibits the VEGF\/VEGFR2\/p38 pathway by targeting HIF-1a in lung adenocarcinoma.\u00a0Phytomedicine.\u00a0129, 155690 (2024).","journal-title":"Phytomedicine"},{"key":"41141_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145796","volume":"798","author":"M Rashid","year":"2021","unstructured":"Rashid, M. et al. Up-down regulation of HIF-1\u03b1 in cancer progression. Gene.\u00a0798, 145796 (2021).","journal-title":"Gene"},{"issue":"1","key":"41141_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09116-x","volume":"10","author":"SE Syafruddin","year":"2019","unstructured":"Syafruddin, S. E. et al. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma. Nat. Commun. 10(1), 1152 (2019).","journal-title":"Nat. Commun."},{"key":"41141_CR45","first-page":"1","volume":"9","author":"L Zhen","year":"2024","unstructured":"Zhen, L. et al. Prognostic value of neutrophil-to-lymphocyte ratio for patients with acute coronary syndrome and obstructive sleep apnea [J]. Cardiovasc. Innovations Appl. 9, 1 (2024).","journal-title":"Cardiovasc. Innovations Appl."},{"issue":"4","key":"41141_CR46","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The genome sequence archive family: Toward explosive data growth and diverse data types. Genomics Proteomics Bioinformatics.\u00a019(4), 578\u2013583 (2021).","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"41141_CR47","unstructured":"Database Resources of the National Genomics Data Center. China National Center for Bioinformation in 2024 [J]. Nucleic Acids Res. 2024, 52 (D1): D18\u2013d32 ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41141-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41141-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41141-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:02:22Z","timestamp":1777510942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41141-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41141"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41141-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Fujian Medical University School and Hospital of Stomatology (No. 2021-FMUSS-024). All procedures were followed in compliance with applicable rules and regulations. The written informed consent was obtained from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The use and reporting of patient-derived tissue in this study were carried out with written informed consent obtained from the patient or their legally authorized representative, permitting its use for research and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"13852"}}